Pediatric Tachycardia: Recognizing and Treating SVT

Supraventricular tachycardia (SVT) is the most common symptomatic arrhythmia in childhood and one of those situations where rapid, structured action makes the difference between a stable and a critically ill child. While sinus tachycardia as a physiological response to fever, pain, or volume depletion is ubiquitous in daily clinical practice, true SVT requires targeted therapy – from vagal maneuvers to weight-based adenosine to synchronized cardioversion. The correct differentiation between these two entities is the first and most critical step in the pediatric tachycardia algorithm.

Pathophysiology of SVT in Childhood

Supraventricular tachycardia encompasses all tachycardias originating above the bifurcation of the bundle of His. In childhood, two mechanisms predominate:

• Atrioventricular reentrant tachycardia (AVRT): The most common mechanism in infants and toddlers. An accessory pathway (e.g., bundle of Kent in Wolff-Parkinson-White syndrome) forms a reentry circuit together with the AV node. The orthodromic form (anterograde conduction via the AV node, retrograde via the accessory pathway) typically shows narrow QRS complexes.
• AV nodal reentrant tachycardia (AVNRT): More common in older children and adolescents. Two functionally distinct pathways within or near the AV node form the reentry circuit.

Less common are ectopic atrial tachycardias or junctional ectopic tachycardias, which may occur particularly in the postoperative period following cardiac surgery.

What all forms of SVT have in common: The heart rate is typically fixed, the onset is abrupt ("like a light switch"), and the QRS complexes are usually narrow (< 0.09 seconds). The hemodynamic significance depends on the heart rate, the duration of the tachycardia, and the age of the child. Infants in particular tolerate sustained SVT poorly and can develop heart failure within hours.

SVT Versus Sinus Tachycardia: The Critical Differentiation

Distinguishing between SVT and sinus tachycardia is the most important clinical step and simultaneously one of the most common sources of error. Both can present with heart rates above 200/min – especially in infants, where the physiological heart rate is inherently higher.

Clinical Differentiating Features

Feature	Sinus Tachycardia	SVT
Onset	Gradual	Abrupt (sudden)
Heart rate	Infant usually < 220/min, child usually < 180/min	Infant often > 220/min, child often > 180/min
Rate variability	Present (beat-to-beat variation)	Absent (fixed rate, "metronome-like")
P waves	Present, normal morphology	Absent or retrograde (after the QRS)
History	Identifiable trigger (fever, dehydration, pain, anemia)	Often no identifiable trigger
Response to volume administration/antipyretics	Rate reduction	No effect

Practical Tips for Differentiation

• Print a rhythm strip and measure precisely: An absolutely regular RR interval distance without any variation strongly suggests SVT.
• Increase ECG amplitude and paper speed (50 mm/s): This significantly facilitates the search for P waves.
• Consider the clinical context: A febrile, dehydrated child with a heart rate of 190/min most likely has sinus tachycardia. An otherwise healthy child who suddenly becomes pale and tachycardic is more likely to have SVT.

When in doubt: If the child is hemodynamically stable, you have time for diagnostics. If the child is unstable, treat according to the PALS tachycardia algorithm – and the therapy will clarify the diagnosis.

The PALS Tachycardia Algorithm: Narrow Complex Tachycardia

The AHA algorithm for pediatric tachycardia with a pulse follows a clear decision logic. The first step is always the assessment of hemodynamic stability.

Signs of Hemodynamic Instability in Children

• Hypotension (assess using age-appropriate values!)
• Altered mental status (lethargy, irritability, unresponsiveness)
• Signs of shock (prolonged capillary refill time > 2 seconds, mottled skin, weak peripheral pulses)
• Respiratory failure (tachypnea, retractions, cyanosis)

Hemodynamically Stable Child with SVT

In a stable child with confirmed or suspected SVT, therapy follows a stepwise approach:

1. Vagal maneuvers 2. Adenosine (weight-based) 3. If unsuccessful: Escalation (repeat adenosine at a higher dose, consider cardioversion or specialist consultation)

Hemodynamically Unstable Child with SVT

In an unstable child:

• Synchronized cardioversion as the primary intervention
• While preparing for cardioversion, a vagal maneuver or adenosine may be attempted, provided this does not delay cardioversion
• Starting dose: 0.5–1 J/kg
• If unsuccessful: Increase to 2 J/kg
• Sedation/analgesia if the child's condition permits (e.g., midazolam 0.1 mg/kg IV or ketamine 1–2 mg/kg IV)

Vagal Maneuvers in Children: Technique and Special Considerations

Vagal maneuvers increase vagal tone and slow conduction through the AV node. Since the AV node is part of the reentry circuit in AVRT and AVNRT, vagal maneuvers can terminate the tachycardia – not just slow it, but actually stop it.

Age-Adapted Vagal Maneuvers

Infants and toddlers (< 1–2 years):

• Ice application to the face: Place a plastic bag filled with ice water or an ice pack on the forehead and bridge of the nose for 15–20 seconds (do not cover the mouth and nose!). This triggers the diving reflex, one of the most potent vagal reflexes.
• No pressure on the eyes! Ocular pressure is contraindicated in infants (risk of retinal injury).

Older children and adolescents:

• Valsalva maneuver: Have the child blow forcefully into an occluded syringe (e.g., 10-ml syringe) or bear down as if having a bowel movement. The modified Valsalva maneuver with subsequent passive leg elevation (45°) has been shown by current evidence to achieve a significantly higher conversion rate than the classic Valsalva maneuver alone.
• Ice water application to the face works well in older children too.
• Carotid sinus massage: Theoretically possible in adolescents but rarely used in pediatric practice.

Important Notes on Vagal Maneuvers

• Always perform continuous ECG monitoring during the maneuver.
• The conversion rate of vagal maneuvers in pediatric SVT is approximately 30–60% – failure is common and should not cause alarm.
• Vagal maneuvers can be repeated but should not inappropriately delay pharmacological therapy.

Adenosine: The First-Line Pharmacotherapy

Adenosine is an ultra-short-acting endogenous nucleoside that blocks AV nodal conduction for a few seconds, thereby interrupting the reentry circuit. Its half-life is less than 10 seconds – this means the administration technique is just as critical as the dosing.

Dosing (Weight-Based)

• First dose: 0.1 mg/kg IV (maximum dose 6 mg)
• Second dose: 0.2 mg/kg IV (maximum dose 12 mg)
• A third dose of 0.2 mg/kg may be considered if the second dose was ineffective.

Administration Technique – The Key to Success

The most common cause of adenosine "failure" is not SVT resistance but faulty administration. Due to the extremely short half-life, the drug must reach the heart before it is metabolized.

Rapid-push technique with a three-way stopcock:

1. Draw up adenosine into a syringe (weight-based dose).
2. Connect a three-way stopcock as close to the heart as possible to a well-running IV access (ideally antecubital vein or upper extremity – the more proximal, the better).
3. Connect the adenosine syringe and a syringe with 5–10 ml of normal saline (0.9% NaCl) to the three-way stopcock.
4. Inject adenosine as a rapid bolus and immediately flush with the normal saline bolus.
5. Perform the entire procedure as quickly as possible – ideally < 1–2 seconds.

Expected Response

• Brief asystole or pronounced bradycardia (a few seconds) – this is desired and should not cause concern.
• Conversion to sinus rhythm in approximately 80–90% of SVT episodes.
• Common but harmless side effects: flushing, chest tightness, brief dyspnea. Older children should be warned in advance: "You're going to feel strange for a few seconds – that's normal and will pass quickly."

Contraindications and Precautions

• Known wide-complex WPW (antidromic AVRT): With wide QRS complexes and known preexcitation, adenosine is potentially dangerous, as AV nodal blockade can facilitate 1:1 conduction via the accessory pathway.
• Heart transplant recipients: Extremely increased sensitivity – reduce dose to one quarter of the standard dose.
• Theophylline/caffeine: Competitive antagonism at the adenosine receptor – higher doses may be required.
• Dipyridamole/carbamazepine: Potentiation of adenosine effect – consider dose reduction.

Wide Complex Tachycardia: When It Gets Complicated

Not every tachycardia in a child presents with narrow QRS complexes. A wide complex tachycardia (QRS ≥ 0.09 seconds) in a child can be:

• SVT with aberrant conduction (rate-dependent bundle branch block)
• SVT with preexcitation (antidromic AVRT in WPW)
• Ventricular tachycardia (rare in childhood but possible – especially with structural heart disease, cardiomyopathy, long QT syndrome, or after cardiac surgery)

The PALS rule of thumb: If you cannot reliably distinguish between SVT with aberration and ventricular tachycardia in a wide complex tachycardia, treat it as ventricular tachycardia.

Management of wide complex tachycardia:

• Stable: Expert consultation, consider amiodarone 5 mg/kg IV over 20–60 minutes
• Unstable: Synchronized cardioversion 0.5–1 J/kg, increase to 2 J/kg

Remember: Verapamil is absolutely contraindicated in children under 1 year of age (risk of refractory cardiovascular collapse) and should only be used in older children with extreme caution and after cardiology consultation.

Special Situations and Pitfalls

SVT in Neonates and Young Infants

Infants can tolerate SVT for hours before becoming symptomatic – but when they do, they often present with signs of heart failure (tachypnea, hepatomegaly, poor feeding, pallor). A heart rate of 250–300/min in an infant with narrow QRS and absent rate variability is SVT until proven otherwise.

SVT After Conversion: Recurrence Prophylaxis

After successful SVT conversion, you should:

• Obtain a 12-lead ECG in sinus rhythm (look for preexcitation/delta wave as an indicator of WPW)
• Consider recurrence prophylaxis (in infants, commonly propranolol; in older children, depending on the mechanism, also flecainide or other antiarrhythmics)
• Arrange a pediatric cardiology referral

Documentation and Communication

Print the rhythm strip at the moment of conversion – the conversion moment itself (the transition from SVT to sinus rhythm, often with a brief pause) is diagnostically extremely valuable for the treating pediatric cardiologists.

Algorithm Summary at a Glance

1. Identify tachycardia with a pulse
2. Assess hemodynamic stability
3. Evaluate QRS width (narrow vs. wide)
4. Differentiate sinus tachycardia vs. SVT
5. For SVT with stability:
   • Vagal maneuvers → Adenosine 0.1 mg/kg IV rapid push → if unsuccessful, adenosine 0.2 mg/kg IV
6. For SVT with instability:
   • Synchronized cardioversion 0.5–1 J/kg → if unsuccessful, 2 J/kg
7. Always: Search for underlying causes, monitoring, expert consultation for treatment-refractory cases

Practical Training

Managing pediatric SVT requires not only theoretical knowledge but above all practical skills: rapid recognition on the monitor, correct performance of vagal maneuvers in infants, flawless rapid-push technique for adenosine, and when it matters most, synchronized cardioversion under time pressure. All of this can be trained realistically in a structured simulation setting. In the PALS Refresher Course by Simulation Tirol, you work through the complete PALS tachycardia algorithm using realistic scenarios – from the stable child with SVT to the decompensating infant requiring immediate cardioversion. This is how you develop the confidence and competence that makes the critical difference in a real emergency.